EUVIMEDScopri EUVIMED
Open access · CC BY-SA 4.0

ROLE OF PROBIOTICS-BASED SUPPLEMENTS IN THE PREVENTION AND TREATMENT OF GESTATIONAL DIABETES MELLITUS

Dr Sumaira Yasmeen, Prof Saadia Sultana, Dr Sadaf Afzal, Dr Wajiha Shadab, Dr Minahil Huda, Mubeen Alif

Genetics and Molecular Research · 2026-07-07

DOI: 10.4238/pgmd2d43 ↗

At a glance

Journal article in Genetics and Molecular Research, published online on 2026-07-07. Written by Dr Sumaira Yasmeen and 5 co-authors. The full text is freely available (open access, CC BY-SA 4.0).

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Gestational diabetes mellitus (GDM) is a common pregnancy-related metabolic disorder, and the effectiveness of probiotic supplementation in preventing GDM and improving glycaemic control in the Pakistani population remains unclear.

Objective

To determine the prevalence of gestational diabetes mellitus (GDM) in at-risk pregnant women taking probiotic-based supplements versus controls, as well as to assess the impact of probiotics on glycaemic control, in relation to the mean change in fasting blood sugar (FBS) in women with GDM.

Methods

A non-randomised controlled trial was conducted at the Department of Gynaecology and Obstetrics at IIMCT Railway Hospital, Rawalpindi from January 2026 to May 2026. One hundred pregnant women with at least one GDM risk factor, aged 18–40 years and with a gestational age of not more than 20 weeks, were recruited. Group A (n=50) underwent standardised probiotic supplementation and routine antenatal care; Group B (n=50) underwent routine antenatal care alone. FBS was measured at baseline, at 24–28 weeks, and four weeks after GDM diagnosis in GDM-positive women. Data analysis was conducted using SPSS version 23.

Results

Participants averaged 26.36±4.21 years in Group A and 28.36±4.06 years in Group B. GDM was confirmed in 7 (14%) women in Group A versus 17 (34%) in Group B (χ²=5.48, p=0.019). Among GDM-positive patients, mean FBS declined from 107.4 to 97.5 mg/dL in Group A (p=0.003), compared with a lesser reduction from 107.5 to 103.2 mg/dL in Group B (p=0.026).

Conclusion

Daily probiotic supplementation was associated with a markedly lower GDM frequency and a greater reduction in fasting blood glucose among women who nonetheless developed GDM.

Cite

APA

Yasmeen, D. S., Sultana, P. S., Afzal, D. S., Shadab, D. W., Huda, D. M., & Alif, M. (2026). ROLE OF PROBIOTICS-BASED SUPPLEMENTS IN THE PREVENTION AND TREATMENT OF GESTATIONAL DIABETES MELLITUS. Genetics and Molecular Research. https://doi.org/10.4238/pgmd2d43

Vancouver

Yasmeen DS, Sultana PS, Afzal DS, Shadab DW, Huda DM, Alif M. ROLE OF PROBIOTICS-BASED SUPPLEMENTS IN THE PREVENTION AND TREATMENT OF GESTATIONAL DIABETES MELLITUS. Genetics and Molecular Research. 2026. doi:10.4238/pgmd2d43

BibTeX
@article{Yasmeen2026,
  author = {Yasmeen, Dr Sumaira and Sultana, Prof Saadia and Afzal, Dr Sadaf and Shadab, Dr Wajiha and Huda, Dr Minahil and Alif, Mubeen},
  title = {ROLE OF PROBIOTICS-BASED SUPPLEMENTS IN THE PREVENTION AND TREATMENT OF GESTATIONAL DIABETES MELLITUS},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/pgmd2d43}
}
Start for free →